Reuters took readers on a deep dive into how U.S. states, cities and hospitals are scrambling to buy ultra-cold freezers that can safely store Pfizer Inc’s COVID-19 vaccine, ignoring advice from the U.S. Centers for Disease Control and Prevention to hold off. The push reveals a lack of infrastructure to support a super cold vaccine campaign, including equipment to store millions of doses of Pfizer’s vaccine at temperatures of minus 70 degrees Celsius (minus 94°F). And it has thrown a spotlight on makers of the niche freezers, which are adding labor and expanding capacity.
Topics of Interest: Health
Type: Reuters Best
Regions: North America
Win Types: Exclusivity
Story Types: Special Report / Insight
Media Types: Text
Customer Impact: Important Regional Story